📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! Tell us what works, what doesn't, and how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community. Please send your feedback to gateway@ukri.org by 11 August 2025.

Ursodeoxycholic acid is associated with a reduction in SARS-CoV-2 infection and reduced severity of COVID-19 in patients with cirrhosis. (2023)

First Author: John BV

Attributed to: Regenerative medicine applications of cholangiocyte organoids funded by UKRI FLF

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/joim.13630

PubMed Identifier: 37018129

Publication URI: http://europepmc.org/abstract/MED/37018129

Type: Journal Article/Review

Volume: 293

Parent Publication: Journal of internal medicine

Issue: 5

ISSN: 0954-6820